Atovaquone Glenmark Pharmaceuticals Europe

Atovaquone is an antimalarial medication used to treat and prevent malaria. It works by stopping the growth of parasites that cause malaria. This medication is available in oral form and is manufactured by Glenmark Pharmaceuticals Europe Limited.

Atovaquone is primarily used to treat and prevent malaria, a disease caused by parasites transmitted through mosquito bites. It is effective against certain strains of malaria parasites. This medication may also be used for other parasitic infections as determined by a healthcare provider. Atovaquone is often considered when other treatments are not suitable or effective.

Common effects of Atovaquone may include nausea, vomiting, diarrhea, and stomach pain. Some users may experience headache, dizziness, or cough. These effects are generally mild and temporary. If any of these effects persist or worsen, it is important to consult a healthcare professional.

Atovaquone should be used with caution in individuals with liver or kidney problems. It is important to inform your healthcare provider about any allergies or other medications you are taking. This medication should be taken with food to enhance absorption. Always follow the advice of a healthcare professional regarding the use of Atovaquone.

Atovaquone may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. It is important to discuss all current medications with a healthcare provider before starting Atovaquone. Alcohol consumption should be avoided as it may increase the risk of side effects.